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Many native cultures use extracts from Xanthozylum plants to topically treat
toothache and joint pain. One active component of these extracts is the alkyla-
mide, hydroxy-a-sanshool, which induces tingling and numbing paresthesia
when applied to the skin or tongue. To understand the physiological mecha-
nisms underlying paresthesias, we sought to identify the molecular targets of
sanshool in the somatosensory system. We first measured the analgesic proper-
ties of sanshool using mouse models of somatosensory behavior. Topical appli-
cation of sanshool on the hind paw of naı¨ve mice did not alter their sensitivity to
noxious thermal or mechanical stimuli. However, in a model of neurogenic in-
flammation, sanshool acutely suppressed inflammatory hypersensitivity to me-
chanical force whereas it did not suppress hypersensitivity to heat. These data
suggest that sanshool inhibits activity of a subset of sensory neurons that trans-
duce mechanical, but not thermal, stimuli. In cultured dorsal root ganglion
(DRG) neurons from mice, sanshool inhibited action potential (AP) firing in
a subset of medium-to-large diameter neurons, which are thought to mediate
mechanotransduction. In contrast, sanshool did not inhibit AP firing in small-
diameter sensory neurons, which predominantly transduce noxious heat. In ad-
dition to size, sensory neurons are distinct in their expression of sensory
neuron-specific voltage-gated sodium channels. Thus the differential effect of
sanshool on sensory neurons may be due to selective activity of sanshool on
different sodium channels. To test this idea, we compared the effects of san-
shool on two sodium channel subtypes that are expressed in sensory neurons,
Nav1.7 and 1.8. Sanshool reduced the magnitude of Nav1.7 and Nav1.8 cur-
rents but caused a hyperpolarizing shift in the steady-state inactivation curve
of Nav1.7 only. Thus intrinsic molecular differences between sensory neurons,
such as expression of different sodium channel subtypes, may underlie specific-
ity of sanshool action.
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Riluzole is a persistent-selective sodium channel inhibitor (SCI), which has
a therapeutic potential to treat several neurological and psychiatric disorders.
SCIs form a large and diverse group, which includes widely different modes
of action. Individual SCIs may be very potent in one protocol, but ineffective
in another. We have developed a method for testing the ‘‘personality’’ of
SCIs, i.e., we assess their potency under different voltage protocols. The pattern
of their relative potencies gives a characteristic fingerprint which shows correla-
tion with specific chemical properties of molecules, and may also predict their
therapeutic profile. We have identified distinct modes of action for specific
groups of SCIs. Riluzole was found to have a unique ‘‘personality’’ type; there-
fore, in this study we performed a detailed analysis of its mode of action. The
classic SCIs lidocaine and carbamazepine as well as the persistent-selective ra-
nolazine were used as reference compounds.We observed a paradoxical inverse
use-dependence and an apparent transient facilitation on sodium channels in the
presence of riluzole (but not of other drugs) when currents were evoked by short
depolarizations: in such protocols, riluzole appeared to be ineffective. On the
other hand, in protocols with prolonged moderate depolarizations the drug
was remarkably potent; suggesting that it strongly enhanced closed state inacti-
vation. Recovery from fast inactivation was significantly impeded by riluzole,
while recovery from slow inactivated state was - remarkably - even slightly ac-
celerated.As a possiblemechanismwepropose that riluzole has an exceptionally
fast binding kinetics, a high affinity for pre-open closed- and fast inactivated
states, while a low affinity for slow inactivated state.
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Chemistry, University of Bari, Bari, Italy.Lubeluzole displays neuroprotective activity in vitro and in vivo. Blockade of
sodium channels (NaCh) was proposed as a main mechanism for preclinical
and clinical efficacy. We studied the molecular determinants for lubeluzole ac-
tion on whole-cell sodium currents in HEK293 cells expressing hNav1.4
NaChs, using patch clamp technique. Lubeluzole and derivatives were synthe-
sized in our laboratories. Effect of racemic lubeluzole and enantiomers on
NaChs was dose- and use-dependent, with IC50 values of 30 mM at 0.1 Hz stim-
ulation frequency and 2 mM at 10 Hz using an holding potential (hp) of 120
mV. These are ~8 and ~18 times lower than the respective IC50 values for the
well-known NaCh blocker mexiletine. The affinity of lubeluzole for the closed
(KR) and inactivated channel (KI) were 840 and 0.03 mM, compared to 800 and
2 mM for mexiletine. Use-dependent block by lubeluzole was inhibited only
partially by F1586C mutation at the local anesthetic molecular receptor, sug-
gesting that lubeluzole may bind at a different but overlapping receptor. Indeed
KR and KI values for lubeluzole binding to F1586C channel were 700 and 0.7
mM. To go further in details, we synthesized two lubeluzole derivatives, each
containing about one half of the parent compound. The aryloxypropanolamine
moiety recalls the structure of clenbuterol, while the benzothiazole moiety is
similar to riluzole, both known NaCh blockers. However, both derivatives dis-
played very poor use-dependent block, with IC50 values greater than 800 mM at
the hp of 120 mV. In conclusion, lubeluzole is a very potent blocker of inac-
tivated sodium channels, which explains its huge use-dependent action. Lube-
luzole probably utilizes binding interactions distinct from those of local
anesthetic-like drugs, which may open the way for the development of new
compounds with peculiar activity on sodium channels (Supported by Tele-
thon-Italy).
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Ranolazine inhibits the increased persistent Naþ current (persistent INa) con-
ducted by NaV1.1 channels encoding epilepsy and migraine associated muta-
tions. We therefore determined the effects of ranolazine on the electrical
activity of cultured rat hippocampal neurons using empirical and computa-
tional modeling approaches. Ranolazine (3mM) produced a 24% reduction
in the number of action potentials (APs) evoked in response to repetitive
(1sec, 0.67Hz) depolarizing current injections (2154 for control and 1653
for ranolazine, pulse 9, p<0.05). With a single current injection of 4sec,
spike cessation occurred at 24035220 msec in the presence of 10mM rano-
lazine (400050 msec for control). Similar results were observed for the an-
ticonvulsants phenytoin (3mM, 13875184 msec) and lacosamide (30mM,
2441553 msec), which bind to fast and slow-inactivated states of Naþ chan-
nels, respectively. Ranolazine enhanced the development of Naþ channel fast
and slow inactivation evaluated with conditioning pre-pulses of either 100,
1000 or 10000 msec, consistent with progressive binding to inactivated states.
Recovery of Naþ channel activity assessed using fast and slow inactivating
voltage protocols was also delayed in the presence of ranolazine. Interest-
ingly, the use-dependent inhibition (25Hz) of Naþ channel activity by rano-
lazine (10mM) was dependent on the duration of the voltage step (3.052.0%
for 2ms and 33.8513.5% for 20ms, p<0.05) suggesting the drug bound to
inactivated state(s). Similar to phenytoin, ranolazine exhibited slow binding
kinetics to HEK293 cells stably expressing hNav1.2 (KON= 1M
1msec1
and KOFF= 5e
5msec1). Computational simulations predicted equal inhibi-
tion of neuronal APs regardless of whether ranolazine binding was con-
strained to fast-inactivated or slow-inactivated states of the Naþ channel.
Ranolazine had no or minimal effects on neuronal KV channels, GABA or
NMDA neurotransmission. In summary, ranolazine inhibits the excitability
of hippocampal neurons by slowly stabilizing the inactivated states of Naþ
channels.
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Ranolazine is an anti-anginal drug previously shown to block persistent cur-
rents of the cardiac voltage gated sodium channel, NaV1.5. The effects of ra-
nolazine, however, have not yet been described in all sodium channel
isoforms. We studied the effects of ranolazine on the neuronal sodium channel
isoform, NaV1.2, and its modulation by extracellular protons. Ionic currents
were measured from Chinese Hamster Ovary (CHO) cells expressing the
